Apolipoprotein C2 (ApoC2)
Surface apolipoprotein on chylomicrons and VLDL that serves as the essential, obligatory co-factor for lipoprotein lipase (LPL).
Standard vs. Optimal Reference Rangesmg/dL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
2.0 - 6.0 mg/dL
General reference distribution across unselected commercial populations.
3.0 - 5.0 mg/dL
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Binds the catalytic domain of endothelial LPL to activate hydrolysis of core triglycerides into free fatty acids.
Differential Diagnosis
Elevated Levels (ApoC2 High)
- •Familial hypertriglyceridemia with functional resistance
- •Metabolic syndrome with elevated VLDL
Low Levels (ApoC2 Low)
- •Familial ApoC2 deficiency (severe chylomicronemia, eruptive xanthomas, pancreatitis)
- •Secondary LPL failure
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for ApoC2
- Targeted organ system imaging or functional dynamic testing related to lipoprotein lipase co-factor
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Apolipoprotein C2 - The New England Journal of Medicine (2021). PMID: 33990124
- [2]ApoC2 Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35222901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Apolipoprotein C2 (ApoC2) into overall healthspan optimization.